We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
116 hedge funds and large institutions have $328M invested in Arcturus Therapeutics in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
57% more call options, than puts
Call options by funds: $5.48M | Put options by funds: $3.48M
0.45% less ownership
Funds ownership: 83.85% → 83.4% (-0.45%)
5% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 40
7% less capital invested
Capital invested by funds: $353M → $328M (-$25.6M)
9% less funds holding
Funds holding: 128 → 116 (-12)
46% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 26
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
116
Holders Change
-12
Holders Change %
-9.38%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
14
Increased
38
Reduced
40
Closed
26
Calls
$5.48M
Puts
$3.48M
Net Calls
+$2M
Net Calls Change
-$3.59M
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$14.7M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.51M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.13M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.5M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.97M |
| 2 |
Morgan Stanley
New York
|
-$3.82M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.79M |
| 4 |
Millennium Management
New York
|
-$3.12M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$2.05M |
